KUALA LUMPUR, May 14 (Bernama) -- Crown Bioscience - a global drug discovery and development services company - has released scientific posters on innovations in CrownBio's Internal R&D focusing on preclinical oncology research.
The library of poster presentations includes details on the development and application of several innovative humanized models, a new largescale ex vivo PDX drug screening service and a novel IDO1 inhibition assay platform.
Collectively, the data demonstrates CrownBio's unique capacity to enhance knowledge, guide development decisions and advance immunotherapy programs.
The scientific posters are now available on-demand and narrated by CrownBio scientists, a statement said.
"We are committed to sharing with scientists globally the cutting-edge tools that are available to accelerate, inform and enlighten contemporary evaluation of cancer therapies and immunotherapies," said CrownBio's vice-president of Translational Oncology, Dr. Henry Li.
The posters were presented at the American Association of Cancer Research's (AACR) 2018 meeting and can be downloaded at https://www.crownbio.com/posters/
No comments:
Post a Comment